Clinical Trials List
Protocol NumberHN-FBPA-001
Not yet recruiting
2025-11-01 - 2027-04-01
Phase I/II
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 林可瀚 Division of Nuclear Medicine
- 李哲皓 Division of Nuclear Medicine
- 姚珊汎 Division of Nuclear Medicine
- Ling-Wei Wang Division of Radiation Therapy
- Yuan-Hung Wu Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
0 participants
